Lixte Biotechnology's stock dropped 16% after proposing to allocate 25% of its reserves to Bitcoin, reflecting a shift in investor interest towards Ethereum. While Bitcoin set a new all-time high at $122,882, Ethereum has performed even better, trading at $4,763 and showing a 58% rise this month. Investors are gravitating towards Ethereum treasury firms which are experiencing significant stock increases; for instance, companies like ETHZilla (180 Life Sciences) and BitMine Immersion have seen their shares rise substantially. The growing interest in Ethereum is reportedly supported by its perceived advantages in the current market, influencing these firms to accumulate ETH instead of BTC. Ethereum treasuries are now holding almost 3% of the total circulating ETH supply, showcasing a solid confidence in ETH's performance compared to Bitcoin.

Source đź”—